Atacama Labs Oy
Company Profile:
Atacama creates additional revenues for pharmaceutical and generic companies by differentiating and improving their existing product portfolios with the PDG TechnologyTM. Atacama offers to pharmaceutical industry a faster galenic development process, improved and easier galenic formulations and highly reliable and efficient contract production in terms of input / output ratio. Based on the highly innovative Pneumatic Dry Granulation (‘PDG TechnologyTM') Atacama is offering the possibility to treat most any kind of API including difficult substances. The PDG TechnologyTM is also highly efficient for oral dissolving tablets due to the innovative granules provided. The technology is optimal for reducing tablet size via increased drugload thereby increasing patient compliance and affording highly suitable platform for fixed combinations. Atacama is looking forward to partner with pharmaceutical companies in galenic development. Do not hesitate to contact us http://www.atacamalabs.com/
Key Products:
Atacama offers fast galenic and formulation development for oral solid forms and for most any kind of substance with an innovative dry granulation technology and contract manufacturing service to the pharmaceutical industry .
Website:
www.atacamalabs.com
